I am an MD, PhD, assistant professor at Aarhus University and head of the Bioassay Laboratory at Aarhus University Hospital. My background combines clinical practice with experimental research in molecular endocrinology.
My research connects growth factor and steroid hormone biology with the development of diagnostics and treatments. I developed a serum bioassay for free and bioactive glucocorticoids that is now undergoing clinical evaluation and laboratory implementation.
I study activin signalling in muscle and bone, combining bioassays, protein design and preclinical disease models to explore treatments for muscle and bone loss. I am principal investigator (PI) for the preclinical bone phenotype characterisation of Keros Therapeutics’ drug candidate KER-065.
I also developed PlasmPort, a platform for delivering nucleic acids and biological medicines into the cytoplasm of cells, and co-founded Enter Therapeutics.
I teach gross anatomy and have experience in anatomy, histology and biochemistry. I have supervised three PhD students and eight research year students. Drawing on my experience as a doctor and researcher, I emphasise the connections between the body's structure, function and disease.
I collaborate with Aarhus University Hospital, Aarhus University's Department of Biomedicine, the University of Copenhagen, Herlev Hospital, Odense University Hospital and Rigshospitalet. International partners include Erasmus MC, the University of Münster and the Swiss Center for Musculoskeletal Biobanking. Industry partners include Keros Therapeutics and Novo Nordisk. These collaborations span bioassays, muscle and bone biology, and the development of new treatments.
I advise pharmaceutical and biotechnology companies, as well as investors, on growth factor biology, drug development and scientific strategy. My experience includes advising Novo Nordisk, Aureka Biotechnologies and Morgan Stanley. I contribute expertise in the TGF-β family of signalling molecules, bioassays and preclinical research.
I lead the laboratory’s development and validation of bioassays for growth factors and steroid hormones, including assessment of their clinical applications.